In the current study, we established a Gata2-L359V mutation knockin mouse model, intending to examine the effect of this mutation on the murine hematopoiesis and the differentiation block of CML cells. This evidence concerns the gene GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive.